0
0
0
0
0
0
0
0
0
0
0
0
The GAD-7 (Generalized Anxiety Disorder 7-item) is the most widely used validated screening and severity measure for generalized anxiety disorder (GAD) and anxiety symptoms in general. Developed by Spitzer, Kroenke, Williams, and Lowe in 2006, the GAD-7 consists of seven items reflecting the core diagnostic criteria for GAD as defined in the DSM-5, each rated on a 0-3 scale based on frequency over the past two weeks.
Anxiety disorders are the most prevalent mental health conditions globally, affecting approximately 301 million people (WHO, 2019). Generalized anxiety disorder alone has a lifetime prevalence of 5-6% and is characterized by excessive, uncontrollable worry about multiple life domains (health, finances, work, family) persisting for at least 6 months. Despite its high prevalence, GAD is frequently underrecognized — studies show that only 35% of patients with anxiety disorders receive appropriate treatment.
The GAD-7 was validated in a large primary care study of 2,740 patients, demonstrating excellent psychometric properties. For generalized anxiety disorder, it has a sensitivity of 89% and specificity of 82% at the optimal cutoff of >=10. Importantly, the GAD-7 also performs well as a screener for other anxiety disorders: panic disorder (sensitivity 74%), social anxiety disorder (sensitivity 72%), and post-traumatic stress disorder (sensitivity 66%), making it a useful general anxiety screening tool.
Scoring maps to four severity levels: 0-4 (minimal anxiety), 5-9 (mild anxiety), 10-14 (moderate anxiety), and 15-21 (severe anxiety). These categories guide clinical decision-making: mild anxiety may benefit from watchful waiting and self-management; moderate anxiety warrants consideration of psychotherapy (especially CBT) and/or pharmacotherapy; severe anxiety typically requires combination treatment and may need psychiatric referral.
The GAD-7 is commonly used alongside the PHQ-9 because anxiety and depression frequently co-occur — approximately 60% of patients with depression also have anxiety, and vice versa. Both instruments use the same timeframe (2 weeks) and response format (0-3 scale), facilitating joint administration. Like the PHQ-9, the GAD-7 is in the public domain and freely available for clinical and research use.
Scoring is straightforward:
Total Score = Sum of all 7 items (range 0-21)
Each item scored: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day.
Severity Categories:
The optimal cutoff for detecting GAD is >=10 (sensitivity 89%, specificity 82%).
Severity 0 (Score 0-4, Minimal): No clinical anxiety. No treatment needed. Severity 1 (5-9, Mild): Mild anxiety. Recommend self-management (relaxation, exercise, mindfulness, sleep hygiene). Monitor at follow-up. Severity 2 (10-14, Moderate): Clinically significant anxiety. Consider CBT and/or SSRI/SNRI medication. Active treatment recommended. Severity 3 (15-21, Severe): Severe anxiety requiring active treatment — CBT and/or pharmacotherapy. Assess for comorbid depression, substance use, and suicidality. Consider psychiatric referral.
Inputs
Results
GAD-7 score of 5 = mild anxiety. Recommend self-management strategies and monitor.
Inputs
Results
GAD-7 score of 18 = severe anxiety. Active treatment with CBT and/or SSRI/SNRI recommended. Psychiatric referral advised.
The GAD-7 is a 7-item self-report questionnaire that screens for and measures the severity of generalized anxiety disorder. It assesses core GAD symptoms: excessive worry, uncontrollability of worry, trouble relaxing, restlessness, irritability, and feeling that something awful will happen. Scored 0-21.
The GAD-7 has a sensitivity of 89% and specificity of 82% for generalized anxiety disorder at a cutoff of 10. It also detects panic disorder (74% sensitivity), social anxiety (72%), and PTSD (66%). The area under the ROC curve is 0.91.
A score of 10 or higher indicates clinically significant anxiety that likely warrants treatment. Even mild anxiety (scores 5-9) may warrant attention if causing functional impairment. A formal diagnosis requires clinical interview confirming excessive worry for at least 6 months.
The GAD-7 is a screening tool, not a diagnostic instrument. A positive screen suggests probable anxiety disorder but does not replace clinical diagnosis. A clinical interview should confirm specific type, duration, functional impact, and rule out medical causes.
For screening: annually or when clinical suspicion arises. For treatment monitoring: every 2-4 weeks during acute treatment, then monthly. A 50% score reduction indicates clinical response.
First-line: CBT (60-80% response rate); SSRIs (sertraline, escitalopram, paroxetine) and SNRIs (venlafaxine, duloxetine) — 50-70% response rate. Combination CBT + medication may be most effective. Buspirone, pregabalin, and hydroxyzine are alternatives.
Yes, the GAD-7 has moderate sensitivity (74%) for panic disorder because panic and GAD share overlapping symptoms. However, a positive GAD-7 cannot distinguish between anxiety disorders — further clinical assessment is needed.
The GAD-7 and PHQ-9 are companion instruments measuring anxiety and depression respectively. About 60% of patients with elevated GAD-7 also have elevated PHQ-9. Administering both provides comprehensive mental health assessment in under 10 minutes.
Yes, validated in older adults. However, elderly patients may underreport psychological symptoms and present with somatic complaints. Sensitivity may be slightly lower. Consider supplementing with the Geriatric Anxiety Scale for older adults.
Yes, the GAD-7 is in the public domain and free to use without permission or licensing fees. It can be reproduced, translated, and incorporated into electronic health records and research studies.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
PHQ-9 (Patient Health Questionnaire)
Psychiatry & Psychology - Depression & Anxiety Scales Calculators
PHQ-2 (Depression Screening)
Psychiatry & Psychology - Depression & Anxiety Scales Calculators
Hamilton Depression Rating Scale (HAM-D)
Psychiatry & Psychology - Depression & Anxiety Scales Calculators
Montgomery-Åsberg Depression Rating Scale (MADRS)
Psychiatry & Psychology - Depression & Anxiety Scales Calculators
Edinburgh Postnatal Depression Scale (EPDS)
Psychiatry & Psychology - Depression & Anxiety Scales Calculators
Beck Depression Inventory (BDI)
Psychiatry & Psychology - Depression & Anxiety Scales Calculators
